Coagulation factor 2 receptor (F2R), also well-known as a protease-activated receptor 1 (PAR1), is the first known thrombin receptor and plays a critical role in transmitting thrombin-mediated activation of intracellular signaling in many types of cells. It has been known that bacterial infections lead to activation of coagulation systems, and recent studies suggest that PAR1 may be critically involved not only in mediating bacteria-induced detrimental coagulation, but also in innate immune and inflammatory responses. Community-acquired pneumonia, which is frequently caused by Streptococcus pneumoniae (S. pneumoniae), is characterized as an intra-alveolar coagulation and an interstitial neutrophilic inflammation. Recently, the role of PAR1 in regulating pneumococcal infections has been proposed. However, the role of PAR1 in pneumococcal infections has not been clearly understood yet. In this review, recent findings on the role of PAR1 in pneumococcal infections and possible underlying molecular mechanisms by which S. pneumoniae regulates PAR1-mediated immune and inflammatory responses will be discussed.
INTRODUCTION
Community-acquired pneumonia (CAP) is a major cause of death in seniors, and thus economical health care burden due to CAP is rapidly increasing in developed countries, where the portion of senior population is rapidly increasing (1~4). Streptococcus pneumoniae (S. pneumoniae), which is also commonly called as pneumococcus, is the most common bacterial cause of CAP in seniors (5~7). Severe pneumococcal infections are characterized by severe lung injury at the early stage of infection, which is followed by detrimental intra-alveolar coagulation and neutrophil-profound inflammation (8) . Lung injury at the early stage of infection is critical step to initiate intravascular dissemination of pneumococcus and develop detrimental systemic infections, such as bacteremia, meningitis, arthritis, and septicemia (8) . We previously reported that type 1 plasminogen activator inhibitor (PAI-1) plays a critical role for protecting against acute lung injury (ALI) and alveolar hemorrhage, and thus loss of PAI-1 results in enhanced mortality due to severe hemorrhagic edema and enhanced dissemination of pneumococcus (8) .
Later, it has also been found that PAI-1 not only protects against pneumococcal infections by inhibiting tissue injury and alveolar hemorrhage, but also acts as an important regulator of innate immune responses against pneumococcal 319 infections (9~11). However, underlying molecular mechanisms by which PAI-1 protects lungs and mice against pneumococcal infections have not been clearly understood yet. Moreover, since PAI-1 is the most powerful and effective serine protease inhibitor in coagulation system, and severe pulmonary infections are characterized with pro-coagulative intra-alveolar coagulation, protective effects of PAI-1 against pulmonary bacterial infections have been continuously challenged by clinicians (12, 13) .
Coagulation factor 2 receptor (F2R) is a thrombin receptor which belongs to a family of membrane protein receptor protease-activating receptors (PARs) (14) . F2R is more commonly called protease-activated receptor 1 (PAR1) and is a key player in coagulation response upon exposure to serine protease thrombin. Recent studies found that PAR1 may contribute to the adverse pathological changes of pneumococcal pneumonia by mediating neutrophil influx into lungs (15~ 17). In these studies, PAR1 was found to play critical role for regulating immune responses against pneumococcal infections by regulating neutrophil migration into alveolar species 
